This finding is consistent with the broader observation that GHS-R1a receptors are expressed in multiple tissues beyond the pituitary, including kidney, heart, and immune cells, suggesting pleiotropic protective functions
The treatment and regenerative medicine approaches discussed are based on research and have not yet been approved by the FDA
Patients have found side effects may decrease by maintaining proper hydration and eating before injection
Subcutaneous (SubQ) injection is the better route for most 5-Amino-1MQ protocols due to consistent absorption kinetics, lower tissue trauma across repeated dosing, and easier self-administration without specialized technique
Kidney dysfunction is associated with retention of many metabolites, including homocysteine and SAH
The primary human data comes from two small Phase 1 and Phase 2 trials by Teichman et al